Long-term Prognosis of Patellar Tendinopathy (Jumper’s Knee) in Young, Elite Volleyball Players: Tendon Changes 11 Years After Baseline

Background: The long-term prognosis of jumper's knee and whether structural changes in the patellar tendon persist is unknown. Purpose: To investigate whether limitations in knee function and structural changes persisted beyond the athletic career of young elite volleyball players. Study Design...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The American journal of sports medicine 2024-11, Vol.52 (13), p.3314-3323
Hauptverfasser: Visnes, Håvard, Bache-Mathiesen, Lena Kristin, Yamaguchi, Tetsuo, Gilhuus, Hans Petter, Algaard, Knut Robert Hector, Hisdal, Erling, Bahr, Roald
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: The long-term prognosis of jumper's knee and whether structural changes in the patellar tendon persist is unknown. Purpose: To investigate whether limitations in knee function and structural changes persisted beyond the athletic career of young elite volleyball players. Study Design: Cohort study; Level of evidence, 2. Methods: Volleyball players (mean ± SD age, 18 ± 0.8 years) enrolled in 2006-2011 in a prospective cohort study were invited in 2020-2022 to a follow-up study. Participants rated their knee function with the Victorian Institute of Sport Assessment–Patellar Tendon (VISA-P) score (baseline and follow-up) and the International Knee Documentation Committee (IKDC) score (follow-up) and reported if jumper's knee had influenced their decision to retire from sport. Tendon thickness and structural changes were assessed with ultrasound (baseline) and magnetic resonance imaging (MRI) (follow-up) of both patellar tendons. Results: We included 138 of 143 former athletes (97%) 11.4 ± 1.6 years after their baseline examination. At baseline, 37 persons (52 knees) had developed jumper's knee. At follow-up, participants reported lower knee function scores in knees diagnosed with jumper's knee at baseline than healthy knees (VISA-P scores: jumper's knee, 81 [95% CI, 70-92]; healthy, 90 [95% CI, 86-94]; P < .001; IKDC scores: jumper's knee, 82 [95% CI, 75-89]; healthy, 92 [95% CI, 91-95]; P < .001). Jumper's knee problems directly caused 7 of the 37 athletes (19%) with jumper's knee at baseline to retire from competitive volleyball. Of the 138 players included, 97 (70%) completed a bilateral MRI examination (194 knees). At follow-up, 38 of the 54 abnormal tendons (70%) had no structural changes (P < .001 vs baseline) while 22 of the 140 normal tendons (16%) had developed structural changes. Clinical symptoms were not correlated with tendon structure at follow-up (VISA-P scores for normal tendons: 85 [95% CI, 73-87]; abnormal: 89 [95% CI, 85-92]; P = .48). Conclusion: Jumper’s knee is not a self-limiting condition; volleyball players who had developed jumper's knee during adolescence reported persistent reductions in knee function 11 years later, leading one-fifth to retire from competitive volleyball. Although approximately 70% of tendons with structural changes at baseline were normal at follow-up, there was no clear relationship between structure and function.
ISSN:0363-5465
1552-3365
1552-3365
DOI:10.1177/03635465241284648